| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Navicure has chosen to focus exclusively on the needs of practices and institutions performing physician billing.
Colorado Hospital Association is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Colorado Hospital Association is based in Greenwood Village, CO. You can find more information on Colorado Hospital Association at www.chha.com
Pet First Health Care is a Jeffersonville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ABC Medical Management is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.